Skip standard navigation links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z

Division of Vector-Borne Infectious Diseases Plague
Plague WHO CC Home Contact Us Plague


Home

Introduction & Global Distribution

On this Page
item Introduction & Global Distribution
item Mission
item Capabilities
item Vision

Plague is a bacterial zoonosis that causes high mortality (>50%) in untreated cases and has epidemic potential. It is best known as the cause of Justinian's Plague (middle 6th century) and the Black Death (middle 14th century), two devastating pandemics that killed millions and altered the course of history. A third lesser-known pandemic, began in China in the late 1800s, and spread to all inhabited continents, causing nearly 30 million cases and over 12 million deaths in the period 1896-1930. The Third, or Modern Pandemic prompted an intensive multinational research effort that resulted in the identification of the causative agent of plague (Yersinia pestis, a gram-negative bacterium) and conclusive evidence that rat fleas transmit the disease to humans during epidemics. Later studies indicated that smaller numbers of cases also arise as a result of persons being bitten by wild rodent fleas, handling infected animals, or inhaling infectious respiratory droplets coughed by persons with plague pneumonia. Others demonstrated that plague bacteria are maintained in nature through transmission cycles involving wild rodent hosts and flea vectors. Armed with this knowledge, public health workers were able to design and implement prevention measures that reduced the incidence and spread of plague in many regions. The effectiveness of these prevention programs was further enhanced in the mid-20th century by the development of improved and rapid diagnostics, effective antibiotics, vaccines, insecticides and rodenticides.

Global Distribution of Plague
Map of world

Despite the scientific advances described above, and the success of some prevention efforts, plague remains a threat in many areas of the world where enzootic foci continue to exist. Outbreaks of hundreds of cases still occur in some countries of Asia, Africa and South America, especially in those regions where persistent foci are situated near human populations living in unsanitary, rat-infested environments (click for link to WHO Weekly Epidemiological Record). In some instances plague outbreaks in developing countries have spread to urban areas, including port cities, which increases the risk of large epidemics and further spread of the disease. In these and other situations changing demographics, behaviors and environmental conditions in he developing world create conditions conducive to increasing numbers of sporadic cases and to the possible geographic spread of plague. Many countries, including the United States, are unlikely to have rat-associated outbreaks, but continue to experience sporadic cases as a result of persons being bitten by infected wild rodent fleas or handling infected animals. Other serious concerns include the recent identification of multidrug resistant Yersinia pestis in Madagascar and the threat that plague might be used as an agent of biowarfare or bioterrorism.

Reducing the risk of human plague depends on the implementation of effective prevention programs that include capabilities for the surveillance, control, and diagnosis of the disease. Appropriate education programs for the general public and health care workers are also critical. The WHOCC-Plague at the Division of Vector-Borne Infectious Diseases actively works with other public health agencies to develop cost-effective plague prevention programs, respond to plague outbreaks, and monitor the status of plague around the world.

Mission
to Top

The specific mission goals of the WHOCC-Plague are to:

  • Provide epidemiologic assistance, including participation in on-site investigations and the planning and execution of epidemic control measures.
  • Consult and collaborate on plague programs and the development of strategies for the prevention of human plague.
  • Provide laboratory diagnostic support in epidemic situations, including the confirmation and characterization of Yersinia pestis isolates.
  • Maintain a Yersinia pestis reference collection for use by the scientific and medical community.
  • Provide special diagnostic reagents through WHO or PAHO to other diagnostic laboratories.
  • Provide training in-country or at DVBID on laboratory diagnosis, surveillance systems, field techniques, and epidemiology.
  • Perform cooperative field and laboratory research on the epidemiology, ecology, control, and diagnosis of plague.

The activities of the WHOCC-Plague are conducted within the Bacterial Zoonoses Branch (BZB), which is under the direction of Joseph Piesman, Ph.D. The Center's activities are performed through the cooperative efforts of the BZB's Plague Section, Diagnostic and Reference Section, and Epidemiology Section, which have expertise in plague surveillance and control, (Plague Section - Chief, Kenneth Gage, Ph.D.), bacteriology, serology and molecular biology (Diagnostic and Reference Section - Chief, May Chu, Ph.D.), and epidemiology and treatment (Epidemiology Section - Chief, Paul Mead, M.D.).

Capabilities
to Top

The WHOCC-Plague is capable of providing:

  • Comprehensive and integrated responses during emergency investigations of human plague in the United States and other countries.
  • On-site evaluations of plague surveillance, diagnosis, prevention and control programs in the United States and other countries.
  • Diagnostic and reference services during outbreaks, routine surveillance activities, or research projects.
  • Diagnostic reagents.
  • Training at the WHOCC-Plague or through on-site workshops held elsewhere in the United States or in other countries.
  • Training materials, manuals and scientific information produced by WHOCC-Plague staff, including sections on surveillance, clinical diagnosis and treatment in WHO's recently revised Plague Manual, a separate WHO-and CDC-sponsored manual on laboratory diagnosis of plague, and numerous book chapters, articles, pamphlets on plague (See Publications section).
  • Sponsorship of international plague workshops, such as those held at the Emerging Infectious Diseases meetings held in Atlanta, Georgia, USA in 1998 and 2000.
Vision
to Top

The WHOCC-Plague will continue to improve and expand its capabilities as a center of excellence on plague prevention. It will support a global plague network to strengthen surveillance, outbreak response and integrated programs of control. Specifically, the Center plans to:

  • Emphasize the development and implementation of effective, sustainable plague prevention programs in the United States and other countries.
  • Continue to develop its core of subject matter experts who can provide consultation and training on all aspects of plague surveillance, prevention, control and diagnosis.
  • Improve its ability to rapidly respond with onsite assistance during threatening plague epidemics or other situations.
  • Evaluate treatment and patient management strategies.
  • Provide enhanced, rapid reference diagnostic services.
  • Expand its molecular epidemiology capabilities.
  • Provide entomological expertise on plague vectors and their role in disease transmission to humans.
  • Increase the capacity for GIS and remote sensing studies of the landscape ecology and epidemiology of plague.
  • Improve its abilities to use GIS and remote sensing as tools for surveillance and estimating human plague risk.
  • Increase the capacities of other plague programs through training programs at the WHOCC or through onsite training workshops.
  • Improve its ability to respond to possible bioterrorism events.
  • Pursue an active research program intended to develop improved methodologies for plague surveillance, prevention, control, and diagnosis.

 

Return to top of page Return to top of page

   

 

CDC Home | Search | Health Topics A-Z |

This page last reviewed March 30, 2005

Division of Vector-Borne Infectious Diseases |
National Center for Infectious Diseases |
Centers for Disease Control and Prevention |
P.O. Box 2087
Fort Collins, Colorado 80522

CDC Privacy Policy | Accessibility |